XML 44 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
3 Months Ended
Jun. 30, 2011
Jun. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (13,238) $ (13,409)
Adjustments to reconcile net loss to cash flows from operating activities:    
Depreciation 1,908 2,105
Share-based compensation expense 5,660 4,456
Other non-cash charges (130) 146
Changes in assets and liabilities:    
Receivables (11,615) 1,050
Inventory, prepaid expenses and other assets 1,918 2,051
Accounts payable and accrued expenses (3,234) (8,202)
Deferred revenue 474 (409)
Other long-term liabilities   4
Payment of non-recourse RISPERDAL CONSTA secured 7% notes principal attributable to original issue discount   (650)
Cash flows used in operating activities (18,257) (12,858)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property, plant and equipment (924) (4,336)
Sales of property, plant and equipment 3 30
Purchases of investments (67,495) (102,790)
Sales and maturities of investments 75,240 135,917
Cash flows provided by investing activities 6,824 28,821
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock for share-based compensation arrangements 8,986 474
Payment of non-recourse RISPERDAL CONSTA secured 7% notes principal   (5,767)
Cash flows provided by (used in) financing activities 8,986 (5,293)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (2,447) 10,670
CASH AND CASH EQUIVALENTS - Beginning of period 38,394 79,324
CASH AND CASH EQUIVALENTS - End of period 35,947 89,994
SUPPLEMENTAL CASH FLOW DISCLOSURE:    
Cash paid for interest   898
Cash paid for taxes   31
Non-cash investing and financing activities:    
Purchased capital expenditures included in accounts payable and accrued expenses $ 720 $ 1,635